Darya Chudova - 15 May 2025 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Chief Technology Officer
Signature
/s/ John G. Saia, as attorney-in-fact for Darya Chudova
Issuer symbol
GH
Transactions as of
15 May 2025
Net transactions value
-$178,510
Form type
4
Filing time
19 May 2025, 19:08:07 UTC
Previous filing
02 Apr 2025
Next filing
02 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Chudova Darya Chief Technology Officer 3100 HANOVER STREET, PALO ALTO /s/ John G. Saia, as attorney-in-fact for Darya Chudova 16 May 2025 0001977179

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH Common Stock Options Exercise $0 +8,705 +12% $0.000000 83,210 15 May 2025 Direct
transaction GH Common Stock Tax liability $178,510 -4,412 -5.3% $40.46 78,798 15 May 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH Restricted Stock Units Options Exercise $0 -8,705 -33% $0.000000 17,411 15 May 2025 Common Stock 8,705 $0.000000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2 This represents a restricted stock unit award granted on August 7, 2023 and vests over a four-year period. 25% of the shares vested on the one-year anniversary of May 15, 2023 and the remaining 75% vest annually during the three-year period thereafter.
F3 Not applicable for Restricted Stock Units.